Literature DB >> 30952382

Identifying Ventricular Arrhythmias and Their Predictors by Applying Machine Learning Methods to Electronic Health Records in Patients With Hypertrophic Cardiomyopathy (HCM-VAr-Risk Model).

Moumita Bhattacharya1, Dai-Yin Lu2, Shibani M Kudchadkar3, Gabriela Villarreal Greenland4, Prasanth Lingamaneni3, Celia P Corona-Villalobos5, Yufan Guan3, Joseph E Marine3, Jeffrey E Olgin6, Stefan Zimmerman7, Theodore P Abraham4, Hagit Shatkay8, Maria Roselle Abraham9.   

Abstract

Clinical risk stratification for sudden cardiac death (SCD) in hypertrophic cardiomyopathy (HC) employs rules derived from American College of Cardiology Foundation/American Heart Association (ACCF/AHA) guidelines or the HCM Risk-SCD model (C-index ∼0.69), which utilize a few clinical variables. We assessed whether data-driven machine learning methods that consider a wider range of variables can effectively identify HC patients with ventricular arrhythmias (VAr) that lead to SCD. We scanned the electronic health records of 711 HC patients for sustained ventricular tachycardia or ventricular fibrillation. Patients with ventricular tachycardia or ventricular fibrillation (n = 61) were tagged as VAr cases and the remaining (n = 650) as non-VAr. The 2-sample ttest and information gain criterion were used to identify the most informative clinical variables that distinguish VAr from non-VAr; patient records were reduced to include only these variables. Data imbalance stemming from low number of VAr cases was addressed by applying a combination of over- and undersampling strategies. We trained and tested multiple classifiers under this sampling approach, showing effective classification. We evaluated 93 clinical variables, of which 22 proved predictive of VAr. The ensemble of logistic regression and naïve Bayes classifiers, trained based on these 22 variables and corrected for data imbalance, was most effective in separating VAr from non-VAr cases (sensitivity = 0.73, specificity = 0.76, C-index = 0.83). Our method (HCM-VAr-Risk Model) identified 12 new predictors of VAr, in addition to 10 established SCD predictors. In conclusion, this is the first application of machine learning for identifying HC patients with VAr, using clinical attributes. Our model demonstrates good performance (C-index) compared with currently employed SCD prediction algorithms, while addressing imbalance inherent in clinical data.
Copyright © 2019 The Authors. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Year:  2019        PMID: 30952382     DOI: 10.1016/j.amjcard.2019.02.022

Source DB:  PubMed          Journal:  Am J Cardiol        ISSN: 0002-9149            Impact factor:   2.778


  11 in total

1.  Toward ECG-based analysis of hypertrophic cardiomyopathy: a novel ECG segmentation method for handling abnormalities.

Authors:  Kasra Nezamabadi; Jacob Mayfield; Pengyuan Li; Gabriela V Greenland; Sebastian Rodriguez; Bahadir Simsek; Parvin Mousavi; Hagit Shatkay; M Roselle Abraham
Journal:  J Am Med Inform Assoc       Date:  2022-10-07       Impact factor: 7.942

Review 2.  Artificial Intelligence Applied to Cardiomyopathies: Is It Time for Clinical Application?

Authors:  Kyung-Hee Kim; Joon-Myung Kwon; Tara Pereira; Zachi I Attia; Naveen L Pereira
Journal:  Curr Cardiol Rep       Date:  2022-09-01       Impact factor: 3.955

Review 3.  Artificial intelligence and machine learning in precision and genomic medicine.

Authors:  Sameer Quazi
Journal:  Med Oncol       Date:  2022-06-15       Impact factor: 3.738

Review 4.  Machine learning for predicting cardiac events: what does the future hold?

Authors:  Brijesh Patel; Partho Sengupta
Journal:  Expert Rev Cardiovasc Ther       Date:  2020-02-23

Review 5.  Machine Learning in Arrhythmia and Electrophysiology.

Authors:  Natalia A Trayanova; Dan M Popescu; Julie K Shade
Journal:  Circ Res       Date:  2021-02-18       Impact factor: 17.367

6.  Differences in microRNA-29 and Pro-fibrotic Gene Expression in Mouse and Human Hypertrophic Cardiomyopathy.

Authors:  Yamin Liu; Junaid Afzal; Styliani Vakrou; Gabriela V Greenland; C Conover Talbot; Virginia B Hebl; Yufan Guan; Rehan Karmali; Jil C Tardiff; Leslie A Leinwand; Jeffrey E Olgin; Samarjit Das; Ryuya Fukunaga; M Roselle Abraham
Journal:  Front Cardiovasc Med       Date:  2019-12-17

7.  Machine learning techniques for arrhythmic risk stratification: a review of the literature.

Authors:  Cheuk To Chung; George Bazoukis; Sharen Lee; Ying Liu; Tong Liu; Konstantinos P Letsas; Antonis A Armoundas; Gary Tse
Journal:  Int J Arrhythmia       Date:  2022-04-01

8.  Learning for Prevention of Sudden Cardiac Death.

Authors:  Natalia A Trayanova
Journal:  Circ Res       Date:  2021-01-21       Impact factor: 17.367

9.  Machine Learning Methods for Identifying Atrial Fibrillation Cases and Their Predictors in Patients With Hypertrophic Cardiomyopathy: The HCM-AF-Risk Model.

Authors:  Moumita Bhattacharya; Dai-Yin Lu; Ioannis Ventoulis; Gabriela V Greenland; Hulya Yalcin; Yufan Guan; Joseph E Marine; Jeffrey E Olgin; Stefan L Zimmerman; Theodore P Abraham; M Roselle Abraham; Hagit Shatkay
Journal:  CJC Open       Date:  2021-02-02

10.  Explanatory Analysis of a Machine Learning Model to Identify Hypertrophic Cardiomyopathy Patients from EHR Using Diagnostic Codes.

Authors:  Nasibeh Zanjirani Farahani; Shivaram Poigai Arunachalam; Divaakar Siva Baala Sundaram; Kalyan Pasupathy; Moein Enayati; Adelaide M Arruda-Olson
Journal:  Proceedings (IEEE Int Conf Bioinformatics Biomed)       Date:  2021-01-13
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.